| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2337/DIAB.44.10.1139 |
| P698 | PubMed publication ID | 7556948 |
| P2093 | author name string | Ziyadeh FN | |
| Sharma K | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hyperglycemia | Q271993 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1139-1146 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator | |
| P478 | volume | 44 |
| Q28535969 | 'Special k' and a loss of cell-to-cell adhesion in proximal tubule-derived epithelial cells: modulation of the adherens junction complex by ketamine |
| Q42378585 | 6. Diabetic Nephropathy |
| Q59809890 | A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy |
| Q92535726 | A Significant Association Between Rhein and Diabetic Nephropathy in Animals: A Systematic Review and Meta-Analysis |
| Q30355733 | A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease. |
| Q35915947 | A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells |
| Q44313580 | ACE-I and ARBs in early diabetic nephropathy |
| Q58612380 | Aberrant DNA methylation of Tgfb1 in diabetic kidney mesangial cells |
| Q36352141 | Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy |
| Q42641988 | Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice |
| Q57649328 | Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats |
| Q47790063 | Adipose differentiation-related protein and regulators of lipid homeostasis identified by gene expression profiling in the murine db/db diabetic kidney |
| Q43931414 | Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells |
| Q40789629 | Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1. |
| Q52609089 | Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes. |
| Q44367135 | Amino acids induce indicators of response to injury in glomerular mesangial cells |
| Q40193234 | An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells |
| Q40560353 | An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy. |
| Q34075013 | Angiogenesis and chronic kidney disease |
| Q39324415 | Assessment of the Anti-Hyperglycaemic, Anti-Inflammatory and Antioxidant Activities of the Methanol Extract of Moringa Oleifera in Diabetes-Induced Nephrotoxic Male Wistar Rats. |
| Q35585339 | Association of Transforming Growth Factor Beta-1 (TGF-β1) Genetic Variation with Type 2 Diabetes and End Stage Renal Disease in Two Large Population Samples from North India |
| Q44686981 | Attenuating effect of Fufang Xueshuantong Capsule on kidney function in diabetic nephropathy model |
| Q35874334 | Autophagy promotes intracellular degradation of type I collagen induced by transforming growth factor (TGF)-β1. |
| Q39224484 | C-Peptide and its intracellular signaling |
| Q39903991 | C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy |
| Q73181271 | Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients |
| Q37335279 | Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. |
| Q37369666 | Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats |
| Q35306426 | Chlorogenic acid improves late diabetes through adiponectin receptor signaling pathways in db/db mice |
| Q35973844 | Circulating TGF-β1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes |
| Q37392107 | Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it? |
| Q35050392 | Connective tissue growth factor: an attractive therapeutic target in fibrotic renal disease |
| Q43134093 | Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments. |
| Q37110641 | DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy. |
| Q36095577 | Decorin deficiency enhances progressive nephropathy in diabetic mice. |
| Q22254569 | Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy |
| Q47964840 | Detection of serum collagen type IV in children with type 1 (insulin-dependent) diabetes mellitus--a longitudinal study |
| Q35560878 | Development of Diabetes Mellitus Several Years after Manifestation of Diabetic Nephropathy: Case Report and Review of Literature |
| Q38227252 | Diabetic nephropathy--emerging epigenetic mechanisms |
| Q34733351 | Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. |
| Q48569238 | Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes |
| Q28582870 | Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response |
| Q47343602 | Effect of the Administration of Solanum nigrum Fruit on Prevention of Diabetic Nephropathy in Streptozotocin-induced Diabetic Rats |
| Q35007388 | Effects of Allium victorialis leaf extracts and its single compounds on aldose reductase, advanced glycation end products and TGF-β1 expression in mesangial cells |
| Q35546208 | Effects of Epigallocatechin-3-Gallate on the Expression of TGF-β1, PKC α/βII, and NF-κB in High-Glucose-Stimulated Glomerular Epithelial Cells. |
| Q36844506 | Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes |
| Q43207567 | Effects of genistein on secretion of extracellular matrix components and transforming growth factor beta in high-glucose-cultured rat mesangial cells |
| Q37232679 | Effects of glucagon-like peptide-1 receptor agonists on renal function |
| Q33792658 | Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy |
| Q37379205 | Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice |
| Q36437819 | Elevated expression of transforming growth factor-beta in adipose tissue from obese mice |
| Q46107711 | Emodin attenuates high glucose-induced TGF-β1 and fibronectin expression in mesangial cells through inhibition of NF-κB pathway |
| Q34986508 | Epigenetic mechanisms in diabetic vascular complications |
| Q92512595 | Epigenetics and epigenomics in diabetic kidney disease and metabolic memory |
| Q34257934 | Exacerbation of diabetic renal alterations in mice lacking vasohibin-1. |
| Q37311890 | FOG2 protein down-regulation by transforming growth factor-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy. |
| Q51759559 | Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF-β1/Smad3 signaling pathway. |
| Q24644869 | Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers |
| Q34648147 | Functional implications of microRNA-215 in TGF-β1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. |
| Q30422127 | Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes |
| Q46790834 | Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli |
| Q39604870 | Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes |
| Q33840481 | Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-{beta} activity in vascular smooth muscle cells |
| Q40296112 | Glucose enhances mesangial cell apoptosis |
| Q80387303 | Glucose modulates handling of apoptotic cells by mesangial cells: involvement of TGF-beta1 |
| Q35745848 | Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. |
| Q78115905 | Growth factors VEGF and TGF-beta1 in peritoneal dialysis |
| Q38189884 | Have we reached the limits for the treatment of diabetic nephropathy? |
| Q40853703 | Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinases A and C. |
| Q40626188 | Hexosamines and TGF-β1use similar signaling pathways to mediate matrix protein synthesis in mesangial cells |
| Q31126617 | High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity |
| Q28119012 | High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells |
| Q28359749 | High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases |
| Q39796701 | High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells |
| Q42347019 | Hydrogen sulfide reduced renal tissue fibrosis by regulating autophagy in diabetic rats |
| Q36116999 | Hyperglycemia: its imminent effects on mammalian nephrogenesis. |
| Q36780416 | Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. |
| Q37342029 | Hypoxia-inducible factor-2α and TGF-β signaling interact to promote normoxic glomerular fibrogenesis |
| Q39473211 | ID1 inhibits USF2 and blocks TGF-β-induced apoptosis in mesangial cells |
| Q90400326 | Identification of key genes and pathways in diabetic nephropathy by bioinformatics analysis |
| Q51869814 | Induction of hyperglycemia in adult intrauterine growth-restricted rats: effects on renal function. |
| Q36117573 | Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy |
| Q37319338 | Inhibiting Amadori-modified albumin formation improves biomarkers of podocyte damage in diabetic rats |
| Q35804221 | Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy |
| Q36366915 | Inhibition of NA(+)/H(+) Exchanger 1 Attenuates Renal Dysfunction Induced by Advanced Glycation End Products in Rats |
| Q53151512 | Inhibition of the expression of TGF-β1 and CTGF in human mesangial cells by exendin-4, a glucagon-like peptide-1 receptor agonist. |
| Q40876230 | Inhibition of type I and III IP(3)Rs by TGF-beta is associated with impaired calcium release in mesangial cells |
| Q26852400 | Inhibitors/antagonists of TGF-β system in kidney fibrosis |
| Q34784162 | Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression |
| Q36699878 | Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells |
| Q42913254 | Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy |
| Q46654427 | Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats |
| Q97646291 | Mechanisms of Herbal Nephroprotection in diabetes mellitus |
| Q35299817 | Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways |
| Q36124250 | MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy. |
| Q35652362 | MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. |
| Q36094855 | MicroRNAs and diabetic complications |
| Q35907222 | MicroRNAs and the glomerulus |
| Q37258870 | MicroRNAs and their role in progressive kidney diseases |
| Q36166755 | MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets |
| Q37146727 | MicroRNAs: potential mediators and biomarkers of diabetic complications. |
| Q28354033 | Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases |
| Q37243359 | Molecular medicine of microRNAs: structure, function and implications for diabetes. |
| Q37092968 | Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy. |
| Q50053973 | Nephroprotective effects of diacylglycerol on diabetic nephropathy in type 2 diabetic rats |
| Q58246147 | Nephroprotective potential ofQuercus infectoriagalls against experimentally induced diabetic nephropathy in rats through inhibition of renal oxidative stress and TGF-β |
| Q37741787 | New pharmacological treatments for improving renal outcomes in diabetes |
| Q40757990 | Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells |
| Q36345732 | Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells |
| Q35162557 | Oryeongsan suppressed high glucose-induced mesangial fibrosis |
| Q54935923 | Osteomeles schwerinae Extract Prevents Diabetes-Induced Renal Injury in Spontaneously Diabetic Torii Rats. |
| Q31864674 | Overexpression of glutamine:fructose-6-phosphate-amidotransferase induces transforming growth factor-beta1 synthesis in NIH-3T3 fibroblasts |
| Q44311052 | Overexpression of the complementary DNA for human glutamine:fructose-6-phosphate amidotransferase in mesangial cells enhances glucose-induced fibronectin synthesis and transcription factor cyclic adenosine monophosphate-responsive element binding ph |
| Q43269412 | Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression. |
| Q38111707 | Pathophysiology of the diabetic kidney. |
| Q44649164 | Peritoneal dialysis: diabetes of the peritoneal cavity |
| Q50795437 | Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects. |
| Q41440241 | Post-transplant diabetes mellitus. The role of immunosuppression |
| Q39126178 | Potential regulatory mechanisms of lncRNA in diabetes and its complications |
| Q44458242 | Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model |
| Q33637693 | Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways |
| Q37210162 | Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice |
| Q41882971 | Protective effect of magnesium on renal function in STZ-induced diabetic rats |
| Q34097328 | Protein kinase C activation and its pharmacological inhibition in vascular disease |
| Q35581300 | Proteinuria in diabetic nephropathy: treatment and evolution |
| Q37430721 | Rac1 promotes TGF-beta-stimulated mesangial cell type I collagen expression through a PI3K/Akt-dependent mechanism. |
| Q34067504 | Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy |
| Q35909055 | Recent developments in epigenetics of acute and chronic kidney diseases |
| Q28205154 | Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms |
| Q36785571 | Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment |
| Q43099042 | Regulation of transforming growth factor-beta1 by insulin in prediabetic African Americans |
| Q37364519 | Regulation of type IV collagen alpha chains of glomerular epithelial cells in diabetic conditions |
| Q34726882 | Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions |
| Q37370688 | Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice |
| Q46091769 | Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts |
| Q38059670 | Role of epigenetic mechanisms in the vascular complications of diabetes. |
| Q40053242 | Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways |
| Q36547055 | Similarities and differences between alpha-tocopherol and gamma-tocopherol in amelioration of inflammation, oxidative stress and pre-fibrosis in hyperglycemia induced acute kidney inflammation |
| Q41643857 | Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model |
| Q42441608 | Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells |
| Q84010026 | Soy protein prevents renal damage in a fructose-induced model of metabolic syndrome via inhibition of NF-kB in male rats |
| Q35629267 | Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. |
| Q42450892 | Suppressions of chronic glomerular injuries and TGF-β1production by HGF in attenuation of murine diabetic nephropathy |
| Q37347217 | TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN |
| Q41469693 | TGF-beta in kidney fibrosis: a target for gene therapy |
| Q28367170 | TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy |
| Q37476582 | TGF-β/Smad3 activates mammalian target of rapamycin complex-1 to promote collagen production by increasing HIF-1α expression |
| Q39418101 | TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition |
| Q39263423 | The Effects of Total Flavonoids from Buckwheat Flowers and Leaves on Renal Damage and PTP1B Expression in Type 2 Diabetic Rats |
| Q44650481 | The Phosphatidylinositol 3-Kinase/Akt Pathway Enhances Smad3-stimulated Mesangial Cell Collagen I Expression in Response to Transforming Growth Factor-β1 |
| Q59048778 | The Role of Transforming Growth Factor-Beta in Diabetic Nephropathy |
| Q44791690 | The effects of smoking and its cessation on 8-epi-PGF2alpha and transforming growth factor-beta 1 in Type 1 diabetes mellitus. |
| Q37590421 | The genetics of diabetic nephropathy. |
| Q37209550 | The pathogenesis of diabetic nephropathy |
| Q24609124 | The role of epigenetics in the pathology of diabetic complications |
| Q34292435 | The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society |
| Q54373570 | The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus. |
| Q53580895 | Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. |
| Q40606151 | Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin |
| Q44762884 | Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo |
| Q34355665 | Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells |
| Q46717261 | Transforming growth factor-beta1 regulation of laminin gamma1 and fibronectin expression and survival of mouse mesangial cells |
| Q28292776 | Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy |
| Q37716694 | Trends in advanced glycation end products research in diabetes mellitus and its complications. |
| Q36297539 | Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy |
| Q47757479 | Tyrosines-740/751 of PDGFRβ contribute to the activation of Akt/Hif1α/TGFβ nexus to drive high glucose-induced glomerular mesangial cell hypertrophy |
| Q77658807 | Ultrastructural examination of corneal epithelium of spontaneously obese, hyperglycemic rats |
| Q92030126 | Urinary Transforming Growth Factor-Beta 1 (uTGF-β1) and Prevalent CKD Risk in HIV-Positive Patients in West Africa |
| Q35739805 | Use of genetic mouse models in the study of diabetic nephropathy |
| Q45147720 | Use of genetic mouse models in the study of diabetic nephropathy |
| Q37360457 | Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy |
| Q54791518 | Vitamin E and probucol reduce urinary lipophilic aldehydes and renal enlargement in streptozotocin-induced diabetic rats. |
| Q53153595 | Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling. |
| Q92272691 | miR-206 Inhibits Cell Proliferation and Extracellular Matrix Accumulation by Targeting Hypoxia-Inducible Factor 1-alpha (HIF-1α) in Mesangial Cells Treated with High Glucose |
Search more.